Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Cyclodextrin-based nanoparticles encapsulating α-mangostin and their drug release behavior: potential carriers of α-mangostin for cancer therapy

Abstract

α-Mangostin (MGS), an anti-cancer compound, is a xanthone derivative and is extracted from the pericarps of mangosteen. MGS exhibits a variety of bioactivities, such as antioxidant, cytotoxic, anti-inflammatory, and antibacterial effects, as well as anticancer activity. However, MGS has not been approved for clinical use because of its poor bioavailability. There have been many efforts to solve this problem by use of drug carriers. Cyclodextrins (CDs) are well known as nontoxic and biodegradable drug carriers and can encapsulate MGS. In this study, we prepared CD-based nanoparticles (CDNPs) by a polyaddition reaction using epichlorohydrin and characterized them by dynamic light scattering and static light scattering coupled with fractionation. The encapsulation of MGS into CDNPs was examined, and we found that the loading ratio of MGS for CDNPs is much higher than that for CDs themselves. The cytotoxicity of the CDNP/MGS complex was examined, indicating the potential of CDNP as a carrier of MGS.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Saurabh P, Paul NS, Amitha KH. Review of procedures used for the extraction of anti-cancer compounds from tropical plants. Anti-Cancer Agents Med Chem. 2015;15:314–26. https://doi.org/10.2174/1871520614666141114202104.

    Article  CAS  Google Scholar 

  2. Loftsson T, Hreinsdóttir D, Másson M. The complexation efficiency. J Incl Phenom Macrocycl Chem. 2007;57:545–52.

    Article  CAS  Google Scholar 

  3. Pinto MMM, Sousa ME, Nascimento MSJ. Xanthone derivatives: new insights in biological activities. Curr Med Chem. 2005;12:2517–38.

    Article  CAS  Google Scholar 

  4. Chun-Nan L, Shiou-Jyh L, Tai-Hua L, Yin-Ching C, Shen-Jeu W. Xanthone derivatives as potential anti-cancer drugs. J Pharm Pharmacol. 1996;48:539–44.

    Article  Google Scholar 

  5. Madalena P, Fátima C, Maria Emília S, Maria S, Jose’ N, Madalena P. Xanthones as inhibitors of growth of human cancer cell lines and their effects on the proliferation of human lymphocytes in vitro. Bioorg Med Chem. 2002;10:3725–30.

    Article  Google Scholar 

  6. Na Y. Recent cancer drug development with xanthone structures. J Pharm Pharmacol. 2009;61:707–12.

    Article  CAS  Google Scholar 

  7. Han AR, Kim JA, Lantvit DD, Kardono LB, Riswan S, Chai H, et al. Cytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen). J Nat Prod. 2009;72:2028–31.

    Article  CAS  Google Scholar 

  8. Hyun-Ah J, Bao-Ning S, William J, Rajendra K, G M, Douglas A, et al. Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). J Agric Food Chem. 2006;54:2077–82.

    Article  Google Scholar 

  9. Pedraza-Chaverri J, Cardenas-Rodriguez N, Orozco-Ibarra M, Perez-Rojas JM. Medicinal properties of mangosteen (Garcinia mangostana). Food Chem Toxicol. 2008;46:3227–39.

    Article  CAS  Google Scholar 

  10. Keigo N, Norimichi N, Tsutomu A, Hideyuki Y, Yasushi O. Inhibiton of cyclooxygenase and prostaglandin E2 synthesis by y-MGS, a xanthone dervative in mangosteen, in C6 rat glioma cell. Biochem Pharmacol. 2002;63:73–79.

    Article  Google Scholar 

  11. Janhom P, Dharmasaroja P. Neuroprotective effects of alpha-mangostin on MPP(+)-induced apoptotic cell death in neuroblastoma SH-SY5Y cells. J Toxicol. 2015;2015:1–11.

    Article  Google Scholar 

  12. Yukihiro A, Yoshihito N, Munekazu I, Yoshinori N. Anti-cancer effects of xanthones from pericarps of mangosteen. Int J Mol Sci. 2008;9:355–70.

    Article  Google Scholar 

  13. U.S. Department of Health and Human Services. Drug Products, Including Biological Products, that Contain Nanomaterials Guidance for Industry. Pharmaceutical Quality/CMC. 2017. https://www.fda.gov/media/109910/download.

  14. Pan-In P, Wongsomboon A, Kokpol C, Chaichanawongsaroj N, Wanichwecharungruang S. Depositing alpha-mangostin nanoparticles to sebaceous gland area for acne treatment. J Pharm Sci. 2015;129:226–32.

    Article  CAS  Google Scholar 

  15. Yostawonkul J, Surassmo S, Namdee K, Khongkow M, Boonthum C, Pagseesing S, et al. Nanocarrier-mediated delivery of alpha-mangostin for non-surgical castration of male animals. Sci Rep. 2017;7:16234–41.

    Article  Google Scholar 

  16. Mochizuki S, Sakurai K. A novel polysaccharide/polynucleotide complex and its application to bio-functional DNA delivery system. Polym J. 2009;41:343–53.

    Article  CAS  Google Scholar 

  17. He Y, Fu P, Shen X, Gao H. Cyclodextrin-based aggregates and characterization by microscopy. Micron. 2008;39:495–516.

    Article  CAS  Google Scholar 

  18. Gidwani B, Vyas A. A comprehensive review on cyclodextrin-based carriers for delivery of chemotherapeutic cytotoxic anticancer drugs. Biomed Res Int. 2015;2015:198–268.

    Article  Google Scholar 

  19. Collins CJ, McCauliff LA, Hyun SH, Zhang Z, Paul LN, Kulkarni A, et al. Synthesis, characterization, and evaluation of pluronic-based beta-cyclodextrin polyrotaxanes for mobilization of accumulated cholesterol from Niemann-Pick type C fibroblasts. Biochemistry. 2013;52:3242–53.

    Article  CAS  Google Scholar 

  20. Zhang J, Ma PX. Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective. Adv Drug Deliv Rev. 2013;65:1215–33.

    Article  CAS  Google Scholar 

  21. Simoes SM, Rey-Rico A, Concheiro A, Alvarez-Lorenzo C. Supramolecular cyclodextrin-based drug nanocarriers. Chem Commun (Camb). 2015;51:6275–89.

    Article  CAS  Google Scholar 

  22. Wei H, Yu CY. Cyclodextrin-functionalized polymers as drug carriers for cancer therapy. Biomater Sci. 2015;3:1050–60.

    Article  CAS  Google Scholar 

  23. Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems. Int J Pharm. 2006;309:129–38.

    Article  CAS  Google Scholar 

  24. Ozdemir N, Erkin J. Enhancement of dissolution rate and bioavailability of sulfamethoxazole by complexation with beta-cyclodextrin. Drug Dev Ind Pharm. 2012;38:331–40.

    Article  Google Scholar 

  25. Rungnim C, Phunpee S, Kunaseth M, Namuangruk S, Rungsardthong K, Rungrotmongkol T, et al. Co-solvation effect on the binding mode of the alpha-mangostin/beta-cyclodextrin inclusion complex. Beilstein J Org Chem. 2015;11:2306–17.

    Article  CAS  Google Scholar 

  26. Phunpee S, Suktham K, Surassmo S, Jarussophon S, Rungnim C, Soottitantawat A, et al. Controllable encapsulation of alpha-mangostin with quaternized beta-cyclodextrin grafted chitosan using high shear mixing. Int J Pharm. 2018;538:21–29.

    Article  CAS  Google Scholar 

  27. Qin X, Bai L, Tan Y, Li L, Song F, Wang Y. β-Cyclodextrin-crosslinked polymeric adsorbent for simultaneous removal and stepwise recovery of organic dyes and heavy metal ions: fabrication, performance and mechanisms. Chem Eng J. 2019;372:1007–18.

    Article  CAS  Google Scholar 

  28. Renard E, Deratani A, Volet G, Sebille B. Preparation and characterization of water soluble high molecular weight β-cyclodextrin-epichlorohydrin polymers. Eur Polym J. 1997;33:49–57.

    Article  CAS  Google Scholar 

  29. Mariuca-Roxana G, Mihai N, Emma-Adriana B, Dumitru L, Corina A. Phase solubility studies and scanning electron microscopy of Dexamethasone inclusion complexes with β-cyclodextrin and hydroxypropyl β -cyclodextrin. Vasile Goldis Univ Press. 2012;22:83–93.

    Google Scholar 

  30. Heydari A, Hassani Y, Sheibani H, Pardakhti A. Water-soluble β-cyclodextrin polymers as drug carriers to improve solubility, thermal stability and controlled release of nifedipine. Pharm Chem J. 2017;51:375–83.

    Article  CAS  Google Scholar 

  31. Salgın S, Salgın U, Ayluçtarhan M. Synthesis of β-cyclodextrin-epichlorohydrin nanospheres: its application for removal of p-nitrophenol. Am Chem Sci J. 2016;16:1–10.

    Article  Google Scholar 

  32. Oswald ST, Alexei AF, Paul GL, Timothy AG. Binding of aliphatic ketones to cyclodextrins in quaeous solution. J Chem Soc, Perkin Trans. 1996;2:1243–49.

    Google Scholar 

  33. Saokham P, Muankaew C, Jansook P, Loftsson T. Solubility of cyclodextrins and drug/cyclodextrin complexes. Molecules. 2018;23:1161–76.

    Article  Google Scholar 

  34. Yong CW, Washington C, Smith W. Structural behaviour of 2-hydroxypropyl-beta-cyclodextrin in water: molecular dynamics simulation studies. Pharm Res. 2008;25:1092–99.

    Article  CAS  Google Scholar 

  35. Alsbaiee A, Smith BJ, Xiao L, Ling Y, Helbling DE, Dichtel WR. Rapid removal of organic micropollutants from water by a porous beta-cyclodextrin polymer. Nature. 2016;529:190–94.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by JST CREST Grant Number JPMJCR1521, Japan. This work was also supported by a JSPS Grant-in-Aid for Scientific Research (B) (Grant Number 17K14073).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Shota Fujii or Kazuo Sakurai.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Doan, V.T.H., Lee, J.H., Takahashi, R. et al. Cyclodextrin-based nanoparticles encapsulating α-mangostin and their drug release behavior: potential carriers of α-mangostin for cancer therapy. Polym J 52, 457–466 (2020). https://doi.org/10.1038/s41428-019-0296-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41428-019-0296-y

This article is cited by

Search

Quick links